Delivery Order SPE2DB22D9304-SPE2DB24FSSP4
Award Date 3/26/24
Potential Completion Date 3/27/24
Potential Value $2.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,063.40 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of 0.5% erythromycin eye ointment. The contract has a completion date of March 29, 2024 and is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB24FDH61 with DLA, worth up to $4,999,999 through 2025. This larger contract vehicle enables DLA to procure a broad range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,330.04 firm fixed-price contract is for the supply of Erythromycin 0.5% eye ointment 3.5g. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $2,126.80 firm fixed-price contract is for the delivery of Erythromycin 0.5% eye ointment. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA, contract 4600082013 under the SPE2DB program, valued up to $4,999,999 through 2025. This IDV enables DLA to issue delivery orders for a broad...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $1,063.40 contract is for the delivery of Erythromycin 0.5% Eye Ointment. This order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA, valued up to $4,999,999 through 2025, which enables the agency to place orders for a broad range of...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,325.60 award is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams. This order is part of a larger indefinite delivery contract (IDV), contract number SPE2DB24FZR72, with a ceiling value of up to $4,999,999 that DMS Pharmaceutical Group holds with DLA to provide a broad range of pharmaceutical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,786.44, is for the supply of the drug erythromycin ophthalmic to support the recurring medical needs of military health facilities. The contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,326.31 firm fixed-price contract is for the delivery of Erythromycin Ophthalmic, a prescription antibiotic eye solution. This delivery order is part of a larger single-award indefinite delivery contract (IDC), valued at up to $499,999,999, held by DMS Pharmaceutical Group with the DLA under...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Erythromycin Ophthalmic, a medical product, with a ceiling value of $1,695.75 and a period of performance through March 6, 2025. The contract is not set aside for any specific socioeconomic program. DMS Pharmaceutical Group Inc....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,786.44, is for the delivery of ERYTHROMYCIN OPHTHALM, a pharmaceutical product, with a completion date of August 17, 2023. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of erythromycin ophthalmic products, with a ceiling value of $2,924.35 and a period of performance through April 7, 2025. DMS Pharmaceutical Group has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- SPE2DB22D9304Indefinite Delivery Contract
- SPE2DB22D9304-SPE2DB24FSSP4Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4564081912 - Erythromycin 0.5% Eye Ointment. The contract has a ceiling value of $2,658.50 and a completion date of March 27, 2024. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract #4600082013 with the DLA, valued up to $4,999,999 through 2025, which enables DLA to issue delivery orders for a broad range of pharmaceutical products to support military health facilities worldwide. The contract has no set-aside designation.
Generated 6/25/24, 2:11 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 3/26/24 |